Quantres Asset Management’s ResMed RMD Stock Holding History

Quantres Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,900	Closed	-$377K	–	251
2017 Q3	$377K	Buy	+4,900	New	+$375K	0.24%	132

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Quantres Asset Management's RMD Position: Q4 2017 in Review

Quantres Asset Management sold out of ResMed (RMD) in Q4 2017, closing a stake of 4,900 shares — an estimated $377K sold.

Quantres Asset Management first reported a position in RMD in Q3 2017 and held it in 1 quarter. The position peaked at $377K in Q3 2017. 415 funds tracked by Wall St. Rank hold RMD as of Q4 2017.

Quantres Asset Management reported no remaining ResMed position as of Q4 2017 after selling out during the quarter.
Quantres Asset Management sold 4,900 ResMed shares in Q4 2017, an estimated $377K.
Quantres Asset Management first reported a position in ResMed in Q3 2017 and held it in 1 quarter.
Quantres Asset Management's ResMed position peaked at $377K in Q3 2017.
415 funds tracked by Wall St. Rank held ResMed as of Q4 2017.

Based on Quantres Asset Management's 13F filing for Q4 2017, filed 5 Jan 2018.